{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:11:22Z","timestamp":1781968282367,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171671"],"award-info":[{"award-number":["82171671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Hospitals Authority\u2019 Ascent Plan","award":["DFL20191402"],"award-info":[{"award-number":["DFL20191402"]}]},{"name":"Scientific Research Common Program of Beijing Municipal Commission of Education","award":["KM202110025007"],"award-info":[{"award-number":["KM202110025007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The objective was to assess the efficacy and safety of low-dose aspirin for the prevention of preterm birth in nulliparous women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Data sources<\/jats:title>\n                <jats:p>We searched PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception to June 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study eligibility criteria<\/jats:title>\n                <jats:p>Randomized controlled trials that compared aspirin to placebo in nulliparous women were eligible.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was reported in accordance with the PRISMA 2020 checklist. The primary outcomes of this study were the rates of preterm birth at less than 37 weeks and less than 34 weeks of gestation. The secondary outcomes included postpartum hemorrhage, placental abruption, cesarean section, any hypertensive disorder of pregnancy and small for gestational age. Relative risks with their 95% confidence intervals were calculated for analysis. Heterogeneity was assessed by Cochran\u2019s Q test and Higgins\u2019s I<jats:sup>2<\/jats:sup>. A random-effects model was used when I<jats:sup>2<\/jats:sup> was &gt;\u200950% to generate the RR and 95% CI; otherwise, a fixed-effects model was used. The risk of publication bias was assessed by funnel plots. We performed sensitivity analysis by sequentially omitting each included study to confirm the robustness of the analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seven studies with a total of 29,029 participants were included in this review. Six studies were assessed as having a low risk of bias or an unclear risk of bias, and one study was judged as having a high risk of bias. In nulliparous women, low-dose aspirin was associated with a significant reduction in the rate of preterm birth at less than 34 weeks of gestational age (RR 0.84,95% CI: 0.71\u20130.99; I<jats:sup>2<\/jats:sup>\u2009=\u20090%; <jats:italic>P<\/jats:italic>\u2009=\u20090.04), but we did not observe a significant difference in the rate of preterm birth at less than 37 weeks of gestation (RR 0.96,95% CI: 0.90\u20131.02; I<jats:sup>2<\/jats:sup>\u2009=\u200931%; <jats:italic>P<\/jats:italic>\u2009=\u20090.18). Low-dose aspirin was associated with a significant increase in the rates of postpartum hemorrhage (RR 1.32,95% CI: 1.14\u20131.54; I<jats:sup>2<\/jats:sup>\u2009=\u20090%; <jats:italic>P<\/jats:italic>\u2009=\u20090.0003), placental abruption (RR 2.18,95% CI: 1.10\u20134.32; I<jats:sup>2<\/jats:sup>\u2009=\u200916%; <jats:italic>P<\/jats:italic>\u2009=\u20090.02) and cesarean section (RR 1.053, 95% CI: 1.001\u20131.108; I<jats:sup>2<\/jats:sup>\u2009=\u20090%; <jats:italic>P<\/jats:italic>\u2009=\u20090.05) in nulliparous women. We also did not observe a significant effect of low-dose aspirin on the rates of any hypertensive disorder of pregnancy (RR 1.05, 95% CI: 0.96\u20131.14; I<jats:sup>2<\/jats:sup>\u2009=\u20099%; <jats:italic>P<\/jats:italic>\u2009=\u20090.28) or small for gestational age (RR 0.96, 95% CI: 0.91\u20131.02; I<jats:sup>2<\/jats:sup>\u2009=\u20090%; <jats:italic>P<\/jats:italic>\u2009=\u20090.16) in nulliparous women. Funnel plots indicated that no significant publication bias existed in this meta-analysis. Except for preterm birth at less than 34 weeks of gestation, placental abruption and cesarean section, the sensitivity analysis showed similar results, which confirmed the robustness of this meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Low-dose aspirin might reduce the risk of preterm birth at less than 34 weeks of gestation in nulliparous women. The use of low-dose aspirin in nulliparous women increased the risk of postpartum hemorrhage and might increase the risk of placental abruption and cesarean section.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-024-06413-2","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T09:01:37Z","timestamp":1712826097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Low-dose aspirin for the prevention of preterm birth in nulliparous women: systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Xin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"issue":"2","key":"6413_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/1471-0528.16544","volume":"128","author":"L Goodfellow","year":"2021","unstructured":"Goodfellow L, Care A, Alfirevic Z. Controversies in the prevention of spontaneous preterm birth in asymptomatic women: an evidence summary and expert opinion. BJOG. 2021;128(2):177\u201394.","journal-title":"BJOG"},{"issue":"10063","key":"6413_CR2","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","volume":"388","author":"L Liu","year":"2016","unstructured":"Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet (London England). 2016;388(10063):3027\u201335.","journal-title":"Lancet (London England)"},{"issue":"9697","key":"6413_CR3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(09)61762-1","volume":"374","author":"The global","year":"2009","unstructured":"The global. Burden of preterm birth. Lancet. 2009;374(9697):1214.","journal-title":"Lancet"},{"issue":"262","key":"6413_CR4","doi-asserted-by":"publisher","first-page":"262sr5","DOI":"10.1126\/scitranslmed.3009871","volume":"6","author":"CE Rubens","year":"2014","unstructured":"Rubens CE, Sadovsky Y, Muglia L, Gravett MG, Lackritz E, Gravett C. Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med. 2014;6(262):262sr5.","journal-title":"Sci Transl Med"},{"issue":"2","key":"6413_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.siny.2015.12.007","volume":"21","author":"M Harrison","year":"2016","unstructured":"Harrison M, Goldenberg R. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21(2):74\u20139.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"6413_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.clp.2020.08.001","volume":"47","author":"N Breslin","year":"2020","unstructured":"Breslin N, Gyamfi-Bannerman C. Current Preterm Birth Prevention Strategies. Clin Perinatol. 2020;47(4):705\u201317.","journal-title":"Clin Perinatol"},{"key":"6413_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejogrb.2018.12.022","volume":"236","author":"A Matei","year":"2019","unstructured":"Matei A, Saccone G, Vogel JP, Armson AB. Primary and secondary prevention of preterm birth: a review of systematic reviews and ongoing randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2019;236:224\u201339.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"6413_CR8","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/1471-0528.15173","volume":"125","author":"N Medley","year":"2018","unstructured":"Medley N, Poljak B, Mammarella S, Alfirevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018;125(11):1361\u20139.","journal-title":"BJOG"},{"issue":"5","key":"6413_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/uog.19063","volume":"51","author":"AH Shennan","year":"2018","unstructured":"Shennan AH. Prediction and prevention of preterm birth: a quagmire of evidence. Ultrasound Obstet Gynecol. 2018;51(5):569\u201370.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"6413_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/AOG.0000000000001923","volume":"129","author":"J Martin","year":"2017","unstructured":"Martin J, D\u02bcAlton M, Jacobsson B, Norman J. Pursuit of Progress toward Effective Preterm Birth reduction. Obstet Gynecol. 2017;129(4):715\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"6413_CR11","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44\u201352.","journal-title":"Obstet Gynecol"},{"issue":"2s","key":"6413_CR12","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2s):S1108\u201319.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"6413_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","volume":"161","author":"ML LeFevre","year":"2014","unstructured":"LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819\u201326.","journal-title":"Ann Intern Med"},{"issue":"5","key":"6413_CR14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"Hypertension in pregnancy","year":"2013","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and gynecologists\u2019 Task Force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122\u201331.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6413_CR15","first-page":"260","volume":"53","author":"WH Organization","year":"2011","unstructured":"Organization WH. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia. Clin Endocrinol. 2011;53(2):260\u20131.","journal-title":"Clin Endocrinol"},{"issue":"23","key":"6413_CR16","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1136\/heartjnl-2011-300949","volume":"97","author":"CWG Redman","year":"2011","unstructured":"Redman CWG. Hypertension in pregnancy: the NICE guidelines. Heart. 2011;97(23):1967.","journal-title":"Heart"},{"issue":"3","key":"6413_CR17","doi-asserted-by":"publisher","first-page":"B7","DOI":"10.1016\/j.ajog.2020.06.003","volume":"223","author":"CA Combs","year":"2020","unstructured":"Combs CA, Montgomery DM. Society for maternal-fetal Medicine Special Statement: checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin. Am J Obstet Gynecol. 2020;223(3):B7\u201311.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6413_CR18","doi-asserted-by":"publisher","first-page":"e1003892","DOI":"10.1371\/journal.pmed.1003892","volume":"19","author":"A Landman","year":"2022","unstructured":"Landman A, de Boer MA, Visser L, Nijman TAJ, Hemels MAC, Naaktgeboren CN, et al. Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): a multicentre, randomised, double-blinded, placebo-controlled trial. PLoS Med. 2022;19(2):e1003892.","journal-title":"PLoS Med"},{"issue":"3","key":"6413_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1055\/a-1226-6599","volume":"81","author":"R Berger","year":"2021","unstructured":"Berger R, Kyvernitakis I, Maul H. Spontaneous Preterm Birth: is Prevention with aspirin possible? Geburtshilfe Frauenheilkd. 2021;81(3):304\u201310.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"12","key":"6413_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"K Davidson","year":"2021","unstructured":"Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E, et al. Aspirin use to prevent Preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326(12):1186\u201391.","journal-title":"JAMA"},{"issue":"6","key":"6413_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/jp.2016.3","volume":"36","author":"AA Allshouse","year":"2016","unstructured":"Allshouse AA, Jessel RH, Heyborne KD. The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial. J Perinatol. 2016;36(6):427\u201331.","journal-title":"J Perinatol"},{"issue":"2","key":"6413_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/AOG.0000000000001848","volume":"129","author":"EOG van Vliet","year":"2017","unstructured":"van Vliet EOG, Askie LA, Mol BWJ, Oudijk MA. Antiplatelet agents and the Prevention of spontaneous Preterm Birth: a systematic review and Meta-analysis. Obstet Gynecol. 2017;129(2):327\u201336.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"6413_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ajog.2018.06.011","volume":"219","author":"M Andrikopoulou","year":"2018","unstructured":"Andrikopoulou M, Purisch SE, Handal-Orefice R, Gyamfi-Bannerman C. Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women. Am J Obstet Gynecol. 2018;219(4):399. e1-e6.","journal-title":"Am J Obstet Gynecol"},{"issue":"10220","key":"6413_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","volume":"395","author":"MK Hoffman","year":"2020","unstructured":"Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet (London England). 2020;395(10220):285\u201393.","journal-title":"Lancet (London England)"},{"key":"6413_CR25","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva: World Health Organization Copyright \u00a9 2012, World Health Organization.; 2012."},{"issue":"9946","key":"6413_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","volume":"384","author":"J Villar","year":"2014","unstructured":"Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):857\u201368.","journal-title":"Lancet"},{"key":"6413_CR27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"6413_CR28","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019","unstructured":"Higgins JPTTJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester (UK): Wiley; 2019.","edition":"2"},{"issue":"3","key":"6413_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"1","key":"6413_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1258\/1355819021927674","volume":"7","author":"J Higgins","year":"2002","unstructured":"Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy. 2002;7(1):51\u201361.","journal-title":"J Health Serv Res Policy"},{"issue":"7414","key":"6413_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"7","key":"6413_CR32","doi-asserted-by":"publisher","first-page":"e022056","DOI":"10.1136\/bmjopen-2018-022056","volume":"8","author":"F Mone","year":"2018","unstructured":"Mone F, Mulcahy C, McParland P, Breathnach F, Downey P, McCormack D, et al. Trial of feasibility and acceptability of routine low-dose aspirin versus early screening test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial. BMJ open. 2018;8(7):e022056.","journal-title":"BMJ open"},{"issue":"10","key":"6413_CR33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/hr.2011.111","volume":"34","author":"A Bakhti","year":"2011","unstructured":"Bakhti A, Vaiman D. Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertens Res. 2011;34(10):1116\u201320.","journal-title":"Hypertens Res"},{"issue":"3","key":"6413_CR34","first-page":"151","volume":"5","author":"A-A Taherian","year":"2002","unstructured":"Taherian A-A, Taherian A, Shirvani A. Prevention of preeclampsia with low-dose aspirin or calcium supplementation. Arch Iran Med. 2002;5(3):151\u20136.","journal-title":"Arch Iran Med"},{"issue":"4","key":"6413_CR35","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","volume":"168","author":"JC Hauth","year":"1993","unstructured":"Hauth JC, Goldenberg RL, Parker CR, Philips JB, Copper RL, DuBard MB, et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol. 1993;168(4):1083\u201391. discussion 91\u20103.","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"6413_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","volume":"329","author":"BM Sibai","year":"1993","unstructured":"Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993;329(17):1213\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"6413_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/10641959509058050","volume":"14","author":"NJ Davies","year":"1995","unstructured":"Davies NJ, Gazvani MR, Farquharson RG, Walkinshaw SA. Low-dose aspirin in the prevention of hypertensive disorders of pregnancy in relatively low-risk nulliparous women. Hypertens Pregnancy. 1995;14(1):49\u201355.","journal-title":"Hypertens Pregnancy"},{"issue":"3","key":"6413_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","volume":"105","author":"J Golding","year":"1998","unstructured":"Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. Br J Obstet Gynaecol. 1998;105(3):293\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"6413_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","volume":"105","author":"YE Rotchell","year":"1998","unstructured":"Rotchell YE, Cruickshank JK, Gay MP, Griffiths J, Stewart A, Farrell B, et al. Barbados Low Dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol. 1998;105(3):286\u201392.","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"6413_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","volume":"110","author":"D Subtil","year":"2003","unstructured":"Subtil D, Goeusse P, Puech F, Lequien P, Biausque S, Breart G, et al. Aspirin (100\u00a0mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (part 1). BJOG. 2003;110(5):475\u201384.","journal-title":"BJOG"},{"issue":"2","key":"6413_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajog.2011.10.866","volume":"206","author":"J Villar","year":"2012","unstructured":"Villar J, Papageorghiou AT, Knight HE, Gravett MG, Iams J, Waller SA, et al. The preterm birth syndrome: a prototype phenotypic classification. Am J Obstet Gynecol. 2012;206(2):119\u201323.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6413_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ajog.2011.10.864","volume":"206","author":"MS Kramer","year":"2012","unstructured":"Kramer MS, Papageorghiou A, Culhane J, Bhutta Z, Goldenberg RL, Gravett M, et al. Challenges in defining and classifying the preterm birth syndrome. Am J Obstet Gynecol. 2012;206(2):108\u201312.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6413_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajog.2011.10.865","volume":"206","author":"RL Goldenberg","year":"2012","unstructured":"Goldenberg RL, Gravett MG, Iams J, Papageorghiou AT, Waller SA, Kramer M, et al. The preterm birth syndrome: issues to consider in creating a classification system. Am J Obstet Gynecol. 2012;206(2):113\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6413_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajog.2016.09.086","volume":"216","author":"F Mone","year":"2017","unstructured":"Mone F, Mulcahy C, McParland P, McAuliffe FM. Should we recommend universal aspirin for all pregnant women? Am J Obstet Gynecol. 2017;216(2):141.e1-e5.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"6413_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","volume":"134","author":"D Mallampati","year":"2019","unstructured":"Mallampati D, Grobman W, Rouse DJ, Werner EF. Strategies for prescribing aspirin to prevent Preeclampsia: a cost-effectiveness analysis. Obstet Gynecol. 2019;134(3):537\u201344.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"6413_CR46","doi-asserted-by":"publisher","first-page":"e2130960","DOI":"10.1001\/jamanetworkopen.2021.30960","volume":"4","author":"AK Lewkowitz","year":"2021","unstructured":"Lewkowitz AK, Rouse DJ. Miscommunication about low-dose aspirin for Preeclampsia Prevention-further support for Universal Prophylaxis. JAMA Netw Open. 2021;4(10):e2130960.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"6413_CR47","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","volume":"72","author":"F Mone","year":"2018","unstructured":"Mone F, O\u2019Mahony JF, Tyrrell E, Mulcahy C, McParland P, Breathnach F, et al. Preeclampsia Prevention using Routine Versus Screening Test-indicated aspirin in low-risk women. Hypertension. 2018;72(6):1391\u20136.","journal-title":"Hypertension"},{"issue":"2","key":"6413_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/GCO.0000000000000694","volume":"33","author":"AR Mather","year":"2021","unstructured":"Mather AR, Dom AM, Thorburg LL. Low-dose aspirin in pregnancy: who? When? How much? And why? Curr Opin Obstet Gynecol. 2021;33(2):65\u201371.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"6413_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejogrb.2021.05.017","volume":"262","author":"R Man","year":"2021","unstructured":"Man R, Hodgetts Morton V, Devani P, Morris RK. Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;262:105\u201312.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"6413_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ajog.2020.07.023","volume":"224","author":"R Hastie","year":"2021","unstructured":"Hastie R, Tong S, Wikstr\u00f6m AK, Sandstr\u00f6m A, Hesselman S, Bergman L. Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. Am J Obstet Gynecol. 2021;224(1):95.e1-e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"6413_CR51","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1055\/s-0040-1718581","volume":"39","author":"AA Eubanks","year":"2022","unstructured":"Eubanks AA, Nobles CJ, Mumford SL, Kim K, Hill MJ, Decherney AH, et al. The safety of low-dose aspirin on the Mode of Delivery: secondary analysis of the Effect of Aspirin in Gestation and Reproduction Randomized Controlled Trial. Am J Perinatol. 2022;39(6):658\u201365.","journal-title":"Am J Perinatol"},{"issue":"4","key":"6413_CR52","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/AOG.0000000000002870","volume":"132","author":"EF Sutton","year":"2018","unstructured":"Sutton EF, Hauspurg A, Caritis SN, Powers RW, Catov JM. Maternal outcomes Associated with Lower Range Stage 1 hypertension. Obstet Gynecol. 2018;132(4):843\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6413_CR53","doi-asserted-by":"publisher","first-page":"e1003908","DOI":"10.1371\/journal.pmed.1003908","volume":"19","author":"V Hodgetts Morton","year":"2022","unstructured":"Hodgetts Morton V, Stock SJ. Low-dose aspirin for the prevention of preterm birth: more questions than answers. PLoS Med. 2022;19(2):e1003908.","journal-title":"PLoS Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-06413-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T09:02:34Z","timestamp":1712826154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-06413-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6413"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-06413-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}